Summary for Patients: Timing of Pegfilgrastim Administration and Pegfilgrastim-Induced Bone Pain

View at publisher Summarise with VIRAT
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chemotherapy can weaken the bone marrow—the part of the body that makes blood cells—making it harder for patients with cancer to fight infections. To help lower this risk, doctors often give a medication called pegfilgrastim, which helps the body produce more infection-fighting white blood cells. Although this medication is helpful, it can cause significant bone pain in some patients. Clinical guidelines recommend giving pegfilgrastim sometime within 1 to 4 days after chemotherapy. Interestingly, some research suggests that giving it later during that time period might lower the chance of bone pain. This study was designed to compare whether giving the …

Fields of Study & Subjects

Neutropenia and Cancer Infections Pain Management and Opioid Use Pharmacovigilance and Adverse Drug Reactions

Publication details

Journal / source
Annals of Internal Medicine
Volume
179
Issue
5
Pages
I–26
Publication date
23 March 2026
Language
EN